Brief: Spruce Biosciences Secures Up To $50 Million In Growth Capital From Avenue Capital
08/01/2026 13:23
Jan 8 (Reuters) - Spruce Biosciences Inc SPRB.O: SPRUCE BIOSCIENCES SECURES UP TO $50 MILLION IN GROWTH CAPITAL FROM AVENUE CAPITAL SPRUCE BIOSCIENCES INC - INITIAL FUNDING OF $15 MILLION EXTENDS CASH RUNWAY INTO 2027 Source text: ID:nBw7vfvXMa Further company coverage: SPRB.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spruce Biosciences
See all newsSpruce Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Spruce Biosciences Q2 net loss widens on higher expenses
Spruce Biosciences, Inc. expected to post a loss of $5.80 a share - Earnings Preview
Brief: Spruce Biosciences Appoints Adrian Quartel, M.D., Ffpm, As Chief Medical Officer
Brief: Spruce Biosciences Announces Data Presentation At The 18Th International MPS Symposium